A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer. Background: Based on the previous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results